Pharmacogenomics of platinum-based chemotherapy in NSCLC

By Hildebrandt Michelle AT   Gu Jian   Wu Xifeng  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 7, 2009-07 ,pp. : 745-755

Informa Healthcare

Access to resources Recommend Favorite

Safety profile of platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer in elderly patients

By Rossi Antonio   Maione Paolo   Gridelli Cesare  

Expert Opinion on Drug Safety, Vol. 4, Iss. 6, 2005-11 ,pp. : 1051-1067

Informa Healthcare

Access to resources Recommend Favorite

Exome Sequencing of Ovarian Cancer Patients to Identify Variants Predictive of Sensitivity to Platinum-based Chemotherapy

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 14, Iss. 2, 2017-04 ,pp. : 124-133

Bentham Science Publishers

Access to resources Recommend Favorite

Association between DNA-repair polymorphisms and survival in pancreatic cancer patients treated with combination chemotherapy

By Giovannetti Elisa   Pacetti Paola   Reni Michele   Leon Leticia G   Mambrini Andrea   Vasile Enrico   Ghidini Michele   Funel Niccola   Lucchesi Matteo   Cereda Stefano   Peters Godefridus J   Cantore Maurizio  

Pharmacogenomics, Vol. 12, Iss. 12, 2011-12 ,pp. : 1641-1652

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics of cisplatin-based chemotherapy in ovarian cancer patients of different ethnic origins

By Khrunin Andrey   Ivanova Feodosia   Moisseev Alexey   Khokhrin Denis   Sleptsova Yuliya   Gorbunova Vera   Limborska Svetlana  

Pharmacogenomics, Vol. 13, Iss. 2, 2012-01 ,pp. : 171-178

Future Medicine

Access to resources Recommend Favorite